OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 05, 2010
Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 02, 2010
Defining the Next Five Years.
A method for determining sample size is finally getting some respect.
FDA wants industry to talk to them about the science underlying process innovations-really.
Chemocatalysis and biocatalysis are important elements of an effective strategy for improving yield and stereoselectivty.
The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?
A Pharma Business Imperative.
Agreement on standards for excipient qualification, development, and fair pricing is underway.
A modular approach to biopharmaceutical production could bring process flexibility, and contract manufacturing organizations are beginning to take notice.